Fertility and Sterility
Volume 91, Issue 5 , Pages 1877-1880, May 2009

Ibuprofen and paracetamol for pain relief during medical abortion: a double-blind randomized controlled study

Department of Obstetrics and Gynecology, Chaim Sheba Medical Center, Tel Hashomer, Israel (affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel)

Received 1 November 2007; received in revised form 22 January 2008; accepted 22 January 2008. published online 25 March 2008.

Objective

To determine the efficacy of a nonsteroidal anti-inflammatory drug vs. paracetamol in pain relief during medical abortion and to evaluate whether nonsteroidal anti-inflammatory drugs interfere with the action of misoprostol.

Design

A prospective double-blind controlled study.

Setting

University-affiliated tertiary hospital.

Patient(s)

One hundred twenty women who underwent first-trimester termination of pregnancy.

Intervention(s)

Patients received 600 mg mifepristone orally, followed by 400 μg of oral misoprostol 2 days later. They were randomized to receive ibuprofen or paracetamol when pain relief was necessary. Patients completed a questionnaire about side effects and pain score and returned for an ultrasound follow-up examination 10–14 days after medical abortion.

Main Outcome Measure(s)

Success rates, as defined by no surgical intervention, and pain scores were assessed.

Result(s)

Ibuprofen was found to be statistically significantly more effective for pain relief after medical abortion compared with paracetamol. There was no difference in the failure rate of medical abortion, and the frequency of surgical intervention was slightly higher in the group that received paracetamol (16.3% vs. 8.5%).

Conclusion(s)

Ibuprofen was found to be more effective than paracetamol for pain reduction during medical abortion. A history of surgical or medical abortion was predictive for high pain scores. Despite its anti-prostaglandin effects, ibuprofen use did not interfere with the action of misoprostol.

Key Words: Medical abortion, pain relief, nonsteroidal anti-inflammatory drugs

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A.L. has nothing to disclose. R.M. has nothing to disclose. L.B.D. has nothing to disclose. M.S. has nothing to disclose. A.M.-Z. has nothing to disclose. D.S.S. has nothing to disclose.

PII: S0015-0282(08)00176-3

doi:10.1016/j.fertnstert.2008.01.084

Fertility and Sterility
Volume 91, Issue 5 , Pages 1877-1880, May 2009